Levoketoconazole: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Levoketoconazole. Educational only — not medical advice.
Labeled uses
RECORLEV is indicated for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative. Limitations of Use RECORLEV is not approved for the treatment of fungal infections. The safety and effectiveness of RECORLEV for the treatment of fungal infections have not been established.
Source: FDA labeling via NIH DailyMed (set d4c5fead…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.